Klinge Biopharma GmbH – Trademark Portfolio
Entity Type: 99
Klinge Biopharma GmbH holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. Currently, 8 trademarks are registered. Notable registered marks include AMAIKE, AFLIBEC, AFLIMAB, AFLIMAC, and AFLIMACUL.
Bergfeldstr. 9
83607 Holzkirchen
Showing of trademarks Trademarks
Trademark Classifications
Klinge Biopharma GmbH's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Klinge Biopharma GmbH have?
Klinge Biopharma GmbH has 13 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 cancelled.
What trademark classes does Klinge Biopharma GmbH file in?
Klinge Biopharma GmbH files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Klinge Biopharma GmbH's most well-known trademarks?
Klinge Biopharma GmbH's registered trademark portfolio includes well-known marks such as AMAIKE, AFLIBEC, AFLIMAB, AFLIMAC, and AFLIMACUL. These are among 8 currently registered trademarks in the portfolio.
What is Klinge Biopharma GmbH's trademark registration success rate?
Klinge Biopharma GmbH has a 89% trademark registration rate, with 8 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.